Russell Investments Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Sell
31,704
-12,721
-29% -$92.8K ﹤0.01% 2785
2025
Q4
$272K Buy
44,425
+22,781
+105% +$246K ﹤0.01% 2723
2025
Q3
$399K Sell
21,644
-1,674
-7% -$26.9K ﹤0.01% 2569
2025
Q2
$303K Buy
23,318
+11,490
+97% +$136K ﹤0.01% 2520
2025
Q1
$125K Buy
11,828
+11,799
+40,686% +$187K ﹤0.01% 2706
2024
Q4
$492 Sell
29
-2,829
-99% -$53.3K ﹤0.01% 3612
2024
Q3
$66.3K Buy
2,858
+792
+38% +$16.9K ﹤0.01% 2735
2024
Q2
$50.3K Buy
2,066
+872
+73% +$26.4K ﹤0.01% 2762
2024
Q1
$40.3K Buy
+1,194
New +$42.3K ﹤0.01% 2696
2023
Q4
Sell
-24
Closed -$613 3209
2023
Q3
$613 Buy
+24
New +$739 ﹤0.01% 3385
2023
Q2
Sell
-4,300
Closed -$103K 3449
2023
Q1
$103K Buy
+4,300
New +$77.1K ﹤0.01% 2585

Other funds holding ARCT